Knowing stock market today at a glance

Why Did Arcturus Therapeutics Plunge 20.2%?

Mover TrackerWednesday, Apr 9, 2025 7:25 am ET

1min read

On April 9, 2025, arcturus therapeutics experienced a significant drop of 20.2% in pre-market trading, reflecting a notable decline in investor sentiment.

Arcturus Therapeutics has seen a substantial portion of its stock, 94.54%, owned by institutional investors and hedge funds, indicating a high level of institutional interest in the company. This institutional ownership can influence market perceptions and trading activities, potentially contributing to the recent volatility.

Recent market conditions have been challenging, with Arcturus Therapeutics' stock reaching a 52-week low of $8.56. This low point underscores the broader market turbulence and the specific challenges faced by the company, which may have contributed to the recent pre-market decline.

Analysts have provided varied price forecasts for Arcturus Therapeutics, with an average target of $57.80 over the next 12 months. The range of estimates, from $41 to $70, suggests a mix of optimism and caution among market experts, reflecting the company's potential for growth amidst current uncertainties.

Arcturus Therapeutics' recent study results for LUNAR-CFTR, also known as ARCT-032, indicated that the treatment was generally safe and well-tolerated. This positive development in the company's pipeline could offer a glimmer of hope for investors, potentially mitigating some of the negative sentiment driving the recent stock decline.

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.